Published ahead of print on May 12, 2008, doi:10.1165/rcmb.2008-0059OC Am. J. Respir. Cell Mol. Biol., Volume 39, Number 5, November 2008, 536-542 A more recent version of this article appeared on November 1, 2008
Submitted on February 4, 2008 Bacterial Peptide Recognition and Immune Activation Facilitated by Human Peptide Transporter PEPT2Peter W Swaan1,1 Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA, 2 The Ohio State University, Davis Heart and Lung Research Institute, Columbus, OH, USA, 3 The Ohio State University, Davis Heart and Lung Research Institute, Columbus, OH, USA; Nationwide Children's Research Institute, Columbus, OH, USA, 4 Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA; ACT LLC, Jenkintown, PA, USA; Department of Pharmacology, University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, Piscataway, NJ, USA * To whom correspondence should be addressed. E-mail: daren.knoell{at}osumc.edu.
Microbial detection requires the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) that are distributed on the cell surface and within the cytosol. The NOD-like receptor (NLR) family functions as an intracellular PRR that triggers the innate immune response. The mechanism by which PAMPs enter the cytosol to interact with NLRs, particularly muropeptides derived from the bacterial proteoglycan cell wall, is poorly understood. PEPT2 is a proton-dependent transporter that mediates the active translocation of di- and tripeptides across epithelial tissues, including the lung. Using computational tools we initially established that bacterial dipeptides, particularly
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||